Close
Back to mobile site

More on CRDL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/13/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cardiol Therapeutics (NQ:CRDL)
Delayed: 1.67 --0 (-0%)
Prev. Close $1.67  
Open$1.67 
52 Wk High$ 
52 Wk Low$ 
Day High$1.67 
Day Low$1.67 
P/E N/A  
EPS$ 
Volume2 


Apr 2, 2024 06:05 AM Form 6-K Cardiol Therapeutics For: Apr 02
Apr 2, 2024 06:02 AM Cardiol Therapeutics (CRDL) Issues FY23 Operations Update
Apr 2, 2024 06:02 AM Cardiol Therapeutics Announces Year-End 2023 Update on Operations
Apr 1, 2024 05:17 PM Form 20-F Cardiol Therapeutics For: Dec 31
Feb 26, 2024 10:07 AM Form 6-K Cardiol Therapeutics For: Feb 26
Feb 21, 2024 07:30 AM Cardiol Therapeutics (CRDL) completes enrollment in its Phase II open-label pilot study of CardiolRx
Feb 21, 2024 07:30 AM Form 6-K Cardiol Therapeutics For: Feb 21
Feb 21, 2024 07:29 AM Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
Feb 15, 2024 07:32 AM Form 6-K Cardiol Therapeutics For: Feb 15
Feb 15, 2024 07:30 AM Cardiol Therapeutics (CRDL) Granted FDA Orphan Drug Designation for Pericarditis
View All Articles

Entities mentioned with CRDL

View All Entities